More than two-thirds of pancreatic cancer patients harboring genetic mutations saw their tumor stop growing…
View More PARP inhibitor shrinks tumors in pancreatic cancer patients with mutations
Home »
Rare angiosarcoma tumors respond well to immunotherapy combination
Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National…
View More Rare angiosarcoma tumors respond well to immunotherapy combination
CAR macrophages go beyond T cells to fight solid tumors
Chimeric antigen receptor (CAR) T cell therapy has been a game-changer for blood cancers but…
View More CAR macrophages go beyond T cells to fight solid tumors
Scientists develop free computer program to map blood flow ‘landscape’ in tumors
Johns Hopkins Medicine researchers have created a computer program for scientists at no charge that…
View More Scientists develop free computer program to map blood flow ‘landscape’ in tumors
$9 million supports deep dive into breast, pancreatic cancers
Washington University School of Medicine in St. Louis has received a $9 million grant from…
View More $9 million supports deep dive into breast, pancreatic cancers